Ken Griffin’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6248 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6317 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6281 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6113 |
|
|
2024
Q2 | – | Sell |
-99
| Closed | -$29.7K | – | 6258 |
|
|
2024
Q1 | $29.7K | Buy |
99
+20
| +25% | +$6.01K | ﹤0.01% | 5461 |
|
|
2023
Q4 | $18.6K | Buy |
+79
| New | +$18.6K | ﹤0.01% | 5390 |
|
|
2023
Q3 | – | Sell |
-21
| Closed | -$3.59K | – | 6104 |
|
|
2023
Q2 | $3.59K | Buy |
+21
| New | +$3.59K | ﹤0.01% | 5495 |
|
|
2023
Q1 | – | Sell |
-503
| Closed | -$152K | – | 6155 |
|
|
2022
Q4 | $152K | Buy |
+503
| New | +$152K | ﹤0.01% | 4834 |
|
|
2022
Q3 | – | Sell |
-108
| Closed | -$6K | – | 6190 |
|
|
2022
Q2 | $6K | Sell |
108
-17
| -14% | -$944 | ﹤0.01% | 5861 |
|
|
2022
Q1 | $14K | Sell |
125
-838
| -87% | -$93.9K | ﹤0.01% | 6182 |
|
|
2021
Q4 | $138K | Buy |
963
+431
| +81% | +$61.8K | ﹤0.01% | 5721 |
|
|
2021
Q3 | $117K | Sell |
532
-536
| -50% | -$118K | ﹤0.01% | 5763 |
|
|
2021
Q2 | $247K | Buy |
1,068
+929
| +668% | +$215K | ﹤0.01% | 5384 |
|
|
2021
Q1 | $42K | Sell |
139
-1,222
| -90% | -$369K | ﹤0.01% | 6127 |
|
|
2020
Q4 | $512K | Buy |
1,361
+186
| +16% | +$70K | ﹤0.01% | 3833 |
|
|
2020
Q3 | $360K | Sell |
1,175
-1,437
| -55% | -$440K | ﹤0.01% | 3720 |
|
|
2020
Q2 | $982K | Buy |
2,612
+791
| +43% | +$297K | ﹤0.01% | 2877 |
|
|
2020
Q1 | $415K | Sell |
1,821
-874
| -32% | -$199K | ﹤0.01% | 3537 |
|
|
2019
Q4 | $1.43M | Sell |
2,695
-1,324
| -33% | -$700K | ﹤0.01% | 2674 |
|
|
2019
Q3 | $1.73M | Buy |
4,019
+239
| +6% | +$103K | ﹤0.01% | 2491 |
|
|
2019
Q2 | $4.51M | Sell |
3,780
-3,607
| -49% | -$4.3M | ﹤0.01% | 1739 |
|
|
2019
Q1 | $9.2M | Sell |
7,387
-580
| -7% | -$723K | ﹤0.01% | 1174 |
|
|
2018
Q4 | $7.55M | Sell |
7,967
-534
| -6% | -$506K | ﹤0.01% | 1168 |
|
|
2018
Q3 | $12.2M | Sell |
8,501
-6,030
| -41% | -$8.68M | 0.01% | 997 |
|
|
2018
Q2 | $23.4M | Buy |
14,531
+2,905
| +25% | +$4.69M | 0.01% | 645 |
|
|
2018
Q1 | $18.9M | Buy |
11,626
+7,495
| +181% | +$12.2M | 0.01% | 659 |
|
|
2017
Q4 | $6.94M | Buy |
4,131
+3,547
| +607% | +$5.96M | ﹤0.01% | 1142 |
|
|
2017
Q3 | $817K | Buy |
584
+361
| +162% | +$505K | ﹤0.01% | 2403 |
|
|
2017
Q2 | $249K | Buy |
+223
| New | +$249K | ﹤0.01% | 3035 |
|